In our study, the correlation between the prognostic gene expression and cancer stem cell score suggests that the risk score of the model composed of CALCRL, MMP14, and SELL is significantly positively correlated with the stem cell score (DNAss), suggesting that the risk of this prognostic model may be closely related to the activity of cancer stem cells. This evidence concerns the gene SELL and cancer.